| Literature DB >> 15090459 |
Holger Kohlhammer1, Carsten Schwaenen, Swen Wessendorf, Karlheinz Holzmann, Hans A Kestler, Dirk Kienle, Thomas F E Barth, Peter Möller, German Ott, Jörg Kalla, Bernhard Radlwimmer, Armin Pscherer, Stephan Stilgenbauer, Hartmut Döhner, Peter Lichter, Martin Bentz.
Abstract
Tumor samples of 53 patients with t(11;14)-positive mantle cell lymphomas (MCLs) were analyzed by matrix-based comparative genomic hybridization (matrix-CGH) using a dedicated DNA array. In 49 cases, genomic aberrations were identified. In comparison to chromosomal CGH, a 50% higher number of aberrations was found and the high specificity of matrix-CGH was demonstrated by fluorescence in situ hybridization (FISH) analyses. The 11q gains and 13q34 deletions, which have not been described as frequent genomic aberrations in MCL, were identified by matrix-CGH in 15 and 26 cases, respectively. For several genomic aberrations, novel consensus regions were defined: 8p21 (size of the consensus region, 2.4 megabase pairs [Mbp]; candidate genes: TNFRSF10B, TNFRSF10C, TNFRSF10D); 10p13 (2.7 Mbp; BMI1); 11q13 (1.4 Mbp; RELA); 11q13 (5.2 Mbp; CCND1); 13q14 (0.4 Mbp; RFP2, BCMSUN) and 13q34 (6.9 Mbp). In univariate analyses correlating genomic aberrations and clinical course, 8p- and 13q14- deletions were associated with an inferior overall survival. These data provide a basis for further studies focusing on the identification of pathogenetically or clinically relevant genes in MCL.Entities:
Mesh:
Year: 2004 PMID: 15090459 DOI: 10.1182/blood-2003-12-4175
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113